SUNDAY, NOVEMBER 11

08.30 - 10.00	Thang Long Ballroom
Plenary Session 1: Safe Blood Donor Programme
Chair: Shigeru Takamoto, Nguyen Anh Tri
08.30 - 09.15
2A-PL1-1	SUCCESSFUL CONVERSION OF FAMILY REPLACEMENT DONORS TO VOLUNTARY DONORS
	D. De Coning (Fourways, Gauteng, South Africa)
09.15 - 10.00
2A-PL1-2	SETTING UP A NATIONAL BLOOD PROGRAMME
	Y. Ayob (National Blood Centre, Kuala Lumpur, Malaysia)
10.00 - 10.30
COFFEE BREAK
10.30 - 12.00	Thang Long Ballroom
Plenary Session 2: Implementation of Transfusion Practice
Chair: Paul Holland, Nguyen Ngoc Minh
10.30 - 11.15
2A-PL2-1	EVIDENCE BASED MEDICINE IN FRANSFUSION MEDICNE: AN UPDATE
	L.J. McCarthy, T. Emmett, D.Smith, P.Holland (Indiana University, Indianapolis, USA)
11.15 - 12.00
2A-PL2-2	TRANSFUSION ERRORS AND THEIR PREVENTION
	P. Robillard (Institut National de Santé Publique, Montreal, Canada)
12.00 - 14.00
LUNCH BREAK, VISIT TO THE EXHIBITION AND POSTERS

14.00 - 15.30	Thang Long Ballroom
Simultaneous Session 1: Transfusion Transmissible Infections
Chair: Silvano Wendel, Bach Khanh Hoa
14.00 - 14.20
2B-S01-1	SCREENING TESTS AND POLICIES: PUBLIC PRESSURE RATIONAL EVIDENCES
	S. Wendel (Hopital Sirio-Libanes, Sao Paulo, Brazil)
14.20 - 14.40
2B-S01-2	RAPID TESTS IN TRANSFUSION TRANSMISSIBLE INFECTION SCREENING
	J.P Allain, S. Owusu-Ofori (University of Cambridge, United Kingdom)
14.40 - 15.00
2B-S01-3	NUCLEIC ACID TESTING IN ASIA
	D. Teo (Centre for Transfusion Medicine, Singapore, Singapore)
15.00 - 15.15
2B-S01-4	MONITORING THE POSSIBLE TRANSMISSION OF HIV BY BLOOD TRANSFUSION IN SOUTH AFRICA: THE HIV LOOKBACK PROGRAMME
	E. Walker, R. Crookes (South African National Blood Service, Roodepoort, South Africa)
15.15 - 15.30
2B-S01-5	HBV-DNA DETECTION IN HBS AG NEGATIVE, ANTI-HBC POSITIVE BLOOD DONORS AND CORRELATION OF VIREMIA WITH OTHER MARKERS - ANTI-HBS, HBE AG, ANTI-HBE AND ALT: MEASURES TO INCREASE SCREEMING EFFICIENCY
	D. Sen, K. Chatterjee, P.Chand (Armed Forces Transfusion Centre, New Delhi, India)
14.00 - 15.30	Function Room 1/2
Simultaneous Session 2: Blood Supply Management
Chair: Judith Chapman, Nguyen Thi Nga
14.00 - 14.20
2B-S02-1	ADEQUATE BLOOD SUPPLY MANAGEMENT
	Y.M. Zhu (Shanghai Blood Center, Shanghai, China)
14.20 - 14.40
2B-S02-2	RECOMMENDATIONS FOR EFFECTIVE BLOOD SUPPLY MANAGEMENT
	J.F. Chapman, G.S. Perera, C. Hyam, R.S.J. Hick (Blood Stocks Management Scheme, London, United Kingdom)
14.40 - 15.00
2B-S01-3	SOLUTIONS FOR EFFECTIVE MANAGEMENT OF PLATELETS
	H.H. Tan (Health Sciences Authority, Singapore, Singapore)
15.00 - 15.15
2B-S02-4	ERIC: AN EFFECTIVE WEB-BASED TOOL FOR THE MANAGEMENT OF AUSTRALIAN BLOOD COMPONENT DISCARD DATA
	N. Waters, D. Jones, E.M. Wood (Australian Red Cross Blood Service, Melbourne, Australia)
15.15 - 15.30
2B-S02-5	AN AUDIT OF EXPIRED BLOOD FROM JANUARY TO DECEMBER 2006 IN NORTHERNTRANSFUSION CENTRE (NTC), ALOR SETAR, MALAYSIA
	S. Zulkifli, A.S.M. Othman, A.R. Mohd Ibrahim (Hospital Alor Setar, Alor Setar, Malaysia)
14.00 - 15.30	Function Room 6/7
Simultaneous Session 3: Basics and Clinical Application in Cell Therapy
Chair: Anneke Brand, Tran Van Binh
14.00 - 14.20
2B-S03-1	BLOOD BANK AND THE DEVELOPMENT OF CELLUAR THERAPIES
	P. Coghlan (Australian Red Cross Blood Service, Melbourne, Australia)
14.20 - 14.40
2B-S03-2	CELLUAR IMMUNOTHERAPY: FROM BENCH TO CLINICAL STUDIES
	E. Seifried (Blood fransfusion centre of the German Red Cross, Frankfurt Am Main, Germany)
14.40 - 15.00
2B-S03-3	EXPERIENCE OF CTL (CYTOTOXIC T-LYMPHOCYTES THERAPY FOR MALIGNANCY)
	S. Takamoto (Aichi Medical University, Aichi, Japan)
15.00 - 15.15
2B-S03-4	EXPRESSION OF P210BCR-ABL PROTEIN ON DENDRITIC CELLS TRANSFECTED WITH K562 RNA INCREASED WHILE THE TRANSFECTEDRNA WAS ELIMINATED
	L. Gao, H.H. Fan (Shanghai Blood Center, Shanghai, China)
15.15 - 15.30
2B-S03-5	ASSAY STANDARDIZATION AS THE FIRST STEP IN PROTOCOL SHARING AND COLLABORATION AT DIFFERENT MEDICAL CENTERS IN SINGAPORE
	T. Soh, P. Law, L. Tan, T. Liu, L. Koh, S. Kee, C.S. Chen, F. Wu, K.K. Heng, Y.T. Goh (National University Hospital, Singapore, Singapore)
15.30 - 16.00
TEA BREAK
16.00 - 17.20	Function Room 1/2
Simultaneous Session 4: Transfusion Transmittable Emerging Infections
Chair: Kit S. Lin, Bach Khanh Hoa
16.00 - 16.20
2B-S04-1	OCCULT HEPATITIS B: AN OVERVIEW
	J.P. Allain, D. Candotti (University of Cambridge, Cambridge, United Kingdom)
16.20 - 16.40
2B-S04-2	BIRD FLU H5N1 IN VIETNAM
	T.Q. Huan (Ministry of Health, Hanoi, Vietnam)
16.40 - 17.00
2B-S04-3	IMPLEMENT SAFE BLOOD TRANSFUSION STRATEGY AND ENSURE SAFETY OF BLOOD FOR MEDICAL AND CLINICAL USE
	X. Liu (Shanghai Blood Center, Shangai, China)
17.00 - 17.20
2B-S04-4	A RETROSPECTIVE STUDY ON OCCULT HEPATITIS B VIRUS (HBV) INFECTION IN INDOCHINESE IMMIGRANTS TO CANADA PHYLOGENETIC ANALYSIS OF THE S-GENE
	P. Andonov, L. Lin, C. Osiowy, E. Grudeski, A. Cameron (Public Health Agency of Canada, Winnipeg, Canada)
16.00 - 17.30	Function Room 6/7
Simultaneous Session 5: Transfusion Systems in Resource Limited Countries
Chair: Diane Teo, Nguyen Ngoc Minh
16.00 - 16.20
2B-S05-1	BUILDING TRANSFUSION SERVICES IN RESOURCE LIMITED COUNTRIES: AN OVERSEAS DEVELOPMENT AID (ODA) PERSPECTIVE
	P. Rogers (CTA, Blood Safety WHO, Hanoi, Vietnam)
16.20 - 16.40
2B-S05-2	CENTRALISATION OF BLOOD CENTERS - AN ESSENTIAL IN DEVELOPING COUNTRIES AND CHALLENGING TASK FOR VIETNAM
	P. Quang Vinh (NHIBT, Hanoi, Vietnam)
16.40 - 17.00
2B-S05-3	BUILDING SOCIAL CAPITAL THROUGH BLOOD DONATION: THE SOCIAL FUTURES PROJECT
	P. Coghlan, M. Alessandrini, A. Carr (Australian Red Cross Blood Service, Melbourne, Australia)
17.00 - 17.15
2B-S05-4	TRENDS IN TRANSFUSION PRACTICE: A SEVEN YEAR RETROSPECTIVE STUDY OF PRESCRIPTION PRACTICES OF BLOOD AND COMPONENTS AT A TERTIARY HOSPITAL IN INDIA
	K. Chaudhary (Dr. R.M.L. Hospital, New Delhi, India)
17.015 - 17.30
2B-S05-5	TRAINING IN CLINICAL RESEARCH RELEVANT TO INTERNATIONAL TRANSFUSION SAFETY
	E.L. Murphy, W. McFarland, M.P. Busch (University of California San Francisco and BSRI, San Francisco, USA)
16.00 - 17.30	Thang Long Ballroom
Simultaneous Session 6: Red Cell Blood Groups
Chair: Geoff Daniels, Buu Mat
16.00 - 16.20
2B-S06-1	RED CELL BLOOD GROUPING IN THE MOLECULAR ERA
	G. Daniels (NHSBT, Bristol, United Kingdom)
16.20 - 16.40
2B-S06-2	MICROARRAY TECHNOLOGY FOR BLOOD GROUP TYPING
	M. Olsson (Lund University Hospital, Lund, Sweden)
16.40 - 17.00
2B-S06-3	THE UTILISATION OF RARE BLOOD DONORS
	S. Nance (American Red Cross, Philadelphia, USA)
17.00 - 17.15
2B-S06-4	MOLECULAR BASIS OF INDIVIDUALS WHO DEVELOPED ANTI-D AND A FAMILY RESEARCH REVEALED A NOVEL RHD ALLELE
	Q. Li, L.-Y. Ye, Z.-H. Guo, Y. Yang, Z.-Y. Zhu (Shanghai Blood Center, Shanghai, China)
17.015 - 17.30
2B-S06-5	PROTEIN MICROARRAYS FOR MULTI-PARAMETER BLOOD GROUP SEROLOGY
	S. Robb, L. Knowles, A. Graham, N. O’Looney, M. Chong Kwan, D.A. Colligan, J. Petrik (Alba Bioscience, Edinburgh, United Kingdom)